Literature DB >> 7767398

Confidential unit exclusion: the North London Blood Transfusion Centre's experience.

M T Brennan1, P E Hewitt, C Moore, G Hall, J A Barbara.   

Abstract

A 'Confidential AIDS Questionnaire' has been used at North London Blood Transfusion Centre (NLBTC) donor sessions since July, 1985. The aim of the questionnaire is to encourage self-exclusion by those donors whose behaviour puts them at risk of HIV infection. In a situation where such individuals cannot avoid donating they can indicate, in confidence, that their blood should not be used for transfusion. Since the introduction of this procedure, an average of 10 donors per month, who admitted relevant risk behaviour, have been permanently excluded and a number of prospective donors have excluded themselves when faced with the questionnaire. We have found the questionnaire to be well accepted by donors. It is a useful adjunct to routine donor selection and microbiological testing of donations in our efforts to minimize transfusion-transmitted infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7767398     DOI: 10.1111/j.1365-3148.1995.tb00185.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  2 in total

1.  Comparison of the prevalence of major transfusion-transmitted infections among Iranian blood donors using confidential unit exclusion in an Iranian population: Transfusion-transmitted infections among Iranian blood donors.

Authors:  Azadeh Omidkhoda; Ahmad Gharehbaghian; Mostafa Jamali; Naser Ahmadbeigi; Seyed Mahmoud Hashemi; Abas Rahimi; Masoud Soleimani
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

2.  Efficacy of the confidential unit exclusion option in blood donors in tehran, iran, determined by using the nucleic Acid testing method in 2008 and 2009.

Authors:  Elham Farhadi; Ahmad Gharehbaghian; Gharib Karimi; Shahram Samiee; Farzaneh Tavasolli; Yahya Salimi
Journal:  Hepat Mon       Date:  2011-11-30       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.